Candriam SCA’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-503,510
Closed -$92.5M 935
2021
Q2
$92.5M Sell
503,510
-106,772
-17% -$19.6M 0.63% 33
2021
Q1
$91.6M Hold
610,282
0.76% 22
2020
Q4
$95.4M Buy
610,282
+47,210
+8% +$7.38M 0.75% 22
2020
Q3
$64.4M Sell
563,072
-1,027
-0.2% -$118K 0.61% 31
2020
Q2
$63.3M Sell
564,099
-11,695
-2% -$1.31M 0.67% 27
2020
Q1
$60.9M Hold
575,794
0.67% 25
2019
Q4
$62.3M Sell
575,794
-55,972
-9% -$6.05M 0.67% 25
2019
Q3
$61.9M Buy
631,766
+66,533
+12% +$6.52M 0.82% 20
2019
Q2
$73.7M Buy
565,233
+181
+0% +$23.6K 0.92% 17
2019
Q1
$76.4M Sell
565,052
-60,845
-10% -$8.23M 0.98% 17
2018
Q4
$60.9M Buy
625,897
+145,077
+30% +$14.1M 0.94% 17
2018
Q3
$66.8M Buy
480,820
+186,778
+64% +$26M 0.89% 18
2018
Q2
$36.5M Buy
294,042
+32,923
+13% +$4.09M 0.58% 33
2018
Q1
$29.1M Sell
261,119
-48,672
-16% -$5.43M 0.5% 36
2017
Q4
$37M Buy
309,791
+40,873
+15% +$4.89M 0.64% 28
2017
Q3
$37.7M Buy
268,918
+46,820
+21% +$6.57M 0.66% 25
2017
Q2
$27M Buy
222,098
+12,701
+6% +$1.55M 0.51% 35
2017
Q1
$25.4M Buy
209,397
+15,797
+8% +$1.92M 0.49% 39
2016
Q4
$23.7M Buy
193,600
+29,033
+18% +$3.55M 0.54% 42
2016
Q3
$20.2M Buy
164,567
+21,156
+15% +$2.59M 0.49% 46
2016
Q2
$16.7M Buy
143,411
+6,017
+4% +$703K 0.44% 63
2016
Q1
$19M Buy
+137,394
New +$19M 0.48% 49
2015
Q4
Sell
-174,944
Closed -$27.4M 643
2015
Q3
$27.4M Sell
174,944
-14,083
-7% -$2.2M 0.67% 26
2015
Q2
$34.2M Sell
189,027
-10,930
-5% -$1.98M 0.71% 24
2015
Q1
$34.7M Buy
199,957
+9,819
+5% +$1.7M 0.7% 29
2014
Q4
$35.2M Buy
+190,138
New +$35.2M 0.74% 28